Health advocates are intensifying calls for congressional action to address the growing Alzheimer’s disease crisis, citing rising cases and insufficient funding for research and patient care. The push comes as recent data projects Alzheimer’s diagnoses to nearly triple by 2050, straining healthcare systems and families.
Alzheimer’s, the most common form of dementia, affects over 6 million Americans, with numbers expected to surge as the population ages. Advocates argue that current federal funding falls short of the need, delaying potential breakthroughs in treatment and care. “We’re at a tipping point,” said a spokesperson for the Alzheimer’s Association. “Without increased support, millions will face this devastating disease without adequate resources.”
Analysts note that legislative proposals, such as the bipartisan Alzheimer’s Caregiver Support Act, aim to expand access to respite care and training for families. However, critics question whether Congress will prioritize healthcare funding amid competing budget demands. “The economic burden of Alzheimer’s is undeniable, but so are other pressing issues like infrastructure and defense,” said a policy analyst at the Brookings Institution.
Looking ahead, experts warn that delayed action could exacerbate disparities in care, particularly for rural and low-income communities. “The longer we wait, the harder and more expensive this crisis becomes,” said a NIH researcher.